ReviewWorld journal of transplantation2025
Impact of the United Network for Organ Sharing allocation criteria changes on temporary mechanical circulatory support use as a bridge to transplant.
Review in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Temporary Mechanical Circulatory Support in Patients in Cardiogenic Shock Requiring Cardiac Surgery: Protected Cardiac Surgery Concept.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporary mechanical circulatory support (tMCS) devices such as intra-aortic balloon pumps, veno-arterial extracorporeal membrane oxygenation, and percutaneous ventricular assist devices, play a major role in supporting patients with end-stage heart failure and bridging them to transplant. In 2018, the United Network for Organ Sharing heart allocation criteria was modified by increasing the number of statuses in the heart transplant waitlist to differentiate and favor the sickest patients awaiting transplantation. Within this new system, patients with tMCS devices receive the highest priority statuses. While the 2018 allocation system has reduced waitlist times and mortality for the highest-priority patients, some studies have shown a concomitant rise in the utilization of tMCS devices as bridge to transplant after its enaction. In this narrative review, we describe these changes in tMCS utilization and provide insights on how the upcoming creation of a continuous distribution allocation system may further impact these trends.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.